Mutant FLT3 signaling contributes to a block in myeloid differentiation (Q28279890)

STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells

Europe PubMed Central

title

Mutant FLT3 signaling contributes to a block in myeloid differentiation (English)

0 references

author name string

Rui Zheng

series ordinal

1

0 references

Donald Small

series ordinal

2

0 references

language of work or name

English

0 references

publication date

December 2005

0 references

published in

Leukemia & Lymphoma

0 references

volume

46

0 references

issue

12

0 references

page(s)

1679-87

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

The structural basis for autoinhibition of FLT3 by the juxtamembrane domain

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500261740

A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Biology of flt3 ligand and receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Flt3 ligand induces tyrosine phosphorylation of gab1 and gab2 and their association with shp-2, grb2, and PI3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3/ITD mutation signaling includes suppression of SHP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

FLT3 mutations in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPα expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740

Expression and Signal Transduction of the FLT3 Tyrosine Kinase Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500261740